NDC 0591-5621 is a Tablet in the Bulk Ingredient category. It is labeled and distributed by Actavis Pharma, Inc..
| Product ID | 0591-5621_b8b40d3c-7cea-4dff-a2d8-2767421283b9 |
| NDC | 0591-5621 |
| Product Type | Bulk Ingredient |
| Proprietary Name | NDC 0591-5621 |
| Dosage Form | Tablet |
| Marketing Start Date | 1987-02-03 |
| Marketing Category | / DRUG FOR FURTHER PROCESSING |
| Labeler Name | Actavis Pharma, Inc. |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA071134 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1987-02-03 |
| Marketing End Date | 2017-08-31 |
| Marketing Category | ANDA |
| Application Number | ANDA071134 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1987-02-03 |
| Marketing End Date | 2017-08-31 |
| Marketing Category | ANDA |
| Application Number | ANDA071134 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1987-02-03 |
| Marketing End Date | 2017-08-31 |
| Ingredient | Strength |
|---|---|
| DIAZEPAM | 2 mg/1 |